Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 17 November 2006:
Vol. 314. no. 5802, pp. 1064 - 1065
DOI: 10.1126/science.314.5802.1064b
Prev | Table of Contents | Next

News of the Week

CHINESE DRUG RESEARCH:
Novartis Invests $100 Million in Shanghai

Richard Stone and Hao Xin

SHANGHAI--Many big pharmaceutical companies have outsourced specific steps in the drug discovery process to China. But Novartis, the Swiss drug giant, is building a $100 million R&D center here that "will encompass all stages of drug development, from early discovery all the way to clinical trials." (Read more.)

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)